|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 02/12/02 | Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading | RE |
| 17/12/17 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +0.63% | -3.06% | +5.78% | -12.71% | -15.01% | +16.50% | -10.12% | +11.88% | +66.12% | 6.67TCr | |
| +1.23% | +2.80% | -4.13% | +2.93% | +3.10% | +38.09% | +200.66% | +172.67% | +247.70% | 5.33TCr | |
| +10.08% | +51.80% | +51.80% | +51.80% | +51.80% | +51.80% | +51.80% | +51.80% | - | 4.81TCr | |
| -1.32% | -7.38% | -2.92% | -12.14% | -33.84% | -57.37% | -56.96% | -61.08% | -5.49% | 3.83TCr | |
| +0.78% | -1.84% | +0.11% | +9.66% | +14.89% | +53.73% | -25.20% | -37.86% | -29.64% | 2.99TCr | |
| +0.84% | +0.36% | +9.43% | +24.32% | +19.14% | +67.62% | +84.46% | +48.39% | +36.14% | 2.35TCr | |
| -5.17% | -12.54% | -9.51% | +6.58% | +83.35% | +58.33% | -55.63% | -84.50% | - | 2.15TCr | |
| -1.21% | +1.12% | +18.20% | +4.84% | +17.97% | +0.90% | +164.17% | +6.96% | - | 2TCr | |
| +1.31% | +3.24% | +20.56% | +14.66% | +9.84% | +81.47% | +157.97% | +38.65% | - | 1.65TCr | |
| -0.22% | -0.95% | -2.68% | +14.29% | +37.44% | +62.78% | +123.12% | +166.71% | +330.29% | 1.64TCr | |
| -0.22% | +4.78% | +1.55% | +29.60% | +31.95% | +139.02% | +229.91% | +348.96% | +2,981.84% | 1.24TCr | |
| +0.78% | -0.44% | +3.45% | +11.56% | -0.17% | +0.54% | -32.45% | -22.99% | -36.06% | 1.15TCr | |
| -1.96% | +8.68% | -19.87% | -18.56% | -33.15% | -34.96% | +605.40% | +318.33% | +4,518.14% | 1.1TCr | |
| +2.35% | -5.54% | -6.87% | +23.00% | +35.96% | +127.08% | +181.55% | +453.12% | - | 988.13Cr | |
| +2.70% | +6.37% | +6.25% | +7.89% | -9.76% | -21.56% | -26.77% | -53.58% | -52.92% | 661.61Cr | |
| -4.22% | -3.11% | -4.04% | -20.10% | +3.94% | +16.89% | +214.13% | +221.80% | - | 565.19Cr | |
| -2.35% | -3.81% | -6.60% | +48.13% | +184.58% | +150.82% | +255.53% | -23.07% | - | 562.12Cr | |
| -5.03% | -1.51% | +11.66% | +4.78% | -7.01% | +8.97% | +44.55% | -21.86% | - | 556.44Cr | |
| -1.65% | +7.00% | +7.60% | -24.08% | -28.54% | -39.26% | +128.87% | +120.41% | +116.00% | 549.15Cr | |
| Average | -0.14% | +0.41% | +4.20% | +8.76% | +19.29% | +37.97% | +117.63% | +87.09% | +742.92% | 2.04TCr | |
| Weighted average by Cap. | +1.03% | +0.41% | +7.57% | +8.67% | +13.15% | +33.10% | +80.05% | +61.83% | +397.88% |
- Stock Market
- Stocks
- Stock
- Sector Amylin Pharmaceuticals LLC
Select your edition
All financial news and data tailored to specific country editions
